ATE472539T1 - Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen - Google Patents

Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen

Info

Publication number
ATE472539T1
ATE472539T1 AT01927217T AT01927217T ATE472539T1 AT E472539 T1 ATE472539 T1 AT E472539T1 AT 01927217 T AT01927217 T AT 01927217T AT 01927217 T AT01927217 T AT 01927217T AT E472539 T1 ATE472539 T1 AT E472539T1
Authority
AT
Austria
Prior art keywords
sup
sub
intermediate products
group
producing substituted
Prior art date
Application number
AT01927217T
Other languages
English (en)
Inventor
Marion Wannamaker
Cornelia Forster
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of ATE472539T1 publication Critical patent/ATE472539T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT01927217T 2000-04-24 2001-04-19 Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen ATE472539T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19932900P 2000-04-24 2000-04-24
PCT/US2001/012769 WO2001081330A2 (en) 2000-04-24 2001-04-19 Process and intermediates for making substituted aspartic acid acetals

Publications (1)

Publication Number Publication Date
ATE472539T1 true ATE472539T1 (de) 2010-07-15

Family

ID=22737094

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01927217T ATE472539T1 (de) 2000-04-24 2001-04-19 Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen

Country Status (15)

Country Link
US (1) US7109357B2 (de)
EP (1) EP1278737B1 (de)
AT (1) ATE472539T1 (de)
AU (2) AU2001253692B2 (de)
BG (1) BG107028A (de)
CA (1) CA2402128A1 (de)
CZ (1) CZ20023506A3 (de)
DE (1) DE60142470D1 (de)
ES (1) ES2347133T3 (de)
IL (1) IL152393A (de)
NO (1) NO20024111D0 (de)
RU (1) RU2002135317A (de)
SK (1) SK15592002A3 (de)
WO (1) WO2001081330A2 (de)
ZA (1) ZA200206658B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053056B2 (en) 1998-07-02 2006-05-30 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
WO2004081184A2 (en) 2003-03-07 2004-09-23 Seminis Vegetable Seeds, Inc. Markerless transformation
AU2003902704A0 (en) * 2003-05-29 2003-06-19 Crc For Waste Management And Pollution Control Limited Of Unsw Process for producing a nanoscale zero-valent metal
EP1718639A2 (de) 2004-02-27 2006-11-08 Vertex Pharmaceuticals Incorporated Caspaseinhibitoren und deren verwendungen
KR101135765B1 (ko) * 2004-03-12 2012-04-23 버텍스 파마슈티칼스 인코포레이티드 아스파르트산 아세탈 카스파아제 억제제의 제조를 위한방법 및 중간체
AU2012201242B2 (en) * 2004-03-12 2014-06-12 Vertex Pharmaceuticals Incorporated Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
CA2566362C (en) * 2004-05-15 2013-09-10 Vertex Pharmaceuticals Incorporated Treating seizures using ice inhibitors
EP1910379B1 (de) * 2005-07-28 2011-10-19 Vertex Pharmaceuticals Incorporated Caspase-hemmer-propharmaka
US8395020B2 (en) 2006-08-31 2013-03-12 Monsanto Technology Llc Methods for rapidly transforming monocots
CN101534824A (zh) * 2006-11-17 2009-09-16 艾博特公司 作为化学活素受体拮抗剂的氨基吡咯烷
WO2010062846A1 (en) * 2008-11-26 2010-06-03 Hammond Gerald B Synthesis of stable organogold compounds and methods of use thereof
SG10201913587WA (en) 2016-02-05 2020-02-27 Denali Therapeutics Inc Inhibitors of receptor-interacting protein kinase 1
DK3552017T3 (da) 2016-12-09 2022-05-16 Denali Therapeutics Inc Forbindelser, der er anvendelige som ripk1-inhibitorer
CN110545835A (zh) 2016-12-23 2019-12-06 A·勒布朗 Caspase-1抑制及其用于预防和治疗神经病症的用途
WO2023137035A1 (en) 2022-01-12 2023-07-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510560A1 (fr) * 1981-07-29 1983-02-04 Synthelabo Procede de preparation d'amino-4 butyramide
DD279672A1 (de) * 1989-01-31 1990-06-13 Akad Wissenschaften Ddr Verfahren zur herstellung von neuen 5-azido-4-halogen-2(5h)-furanonen
DD279673A1 (de) * 1989-01-31 1990-06-13 Akad Wissenschaften Ddr Verfahren zur herstellung von neuen 4,5-diazido-2(5h)-furanonen
FR2766188B1 (fr) * 1997-07-15 2000-02-11 Hoechst Marion Roussel Inc Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes

Also Published As

Publication number Publication date
AU5369201A (en) 2001-11-07
RU2002135317A (ru) 2004-04-10
EP1278737A2 (de) 2003-01-29
US20030119899A1 (en) 2003-06-26
ES2347133T3 (es) 2010-10-26
CZ20023506A3 (cs) 2003-01-15
CA2402128A1 (en) 2001-11-01
WO2001081330A2 (en) 2001-11-01
WO2001081330A3 (en) 2002-03-07
HK1053307A1 (en) 2003-10-17
IL152393A (en) 2008-03-20
BG107028A (bg) 2003-06-30
US7109357B2 (en) 2006-09-19
IL152393A0 (en) 2003-05-29
NO20024111L (no) 2002-08-28
SK15592002A3 (sk) 2003-04-01
NO20024111D0 (no) 2002-08-28
AU2001253692B2 (en) 2006-11-02
DE60142470D1 (de) 2010-08-12
ZA200206658B (en) 2004-04-28
EP1278737B1 (de) 2010-06-30

Similar Documents

Publication Publication Date Title
DE60142470D1 (de) Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen
ATE174589T1 (de) Verfahren zur herstellung von piperidinderivaten
DE60203595D1 (de) Stabilisierte o-iodoxybenzoesäurezusammensetzungen und verfahren zu ihrer herstellung
DE60011396D1 (de) Verfahren zur herstellung von iopamidol
DE59606057D1 (de) Verfahren zur herstellung von dihydroxypyrimidin-derivaten
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE277915T1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
ATE250057T1 (de) Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60116201D1 (de) Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen
ATE241594T1 (de) N-phenylacetoacetamide und verfahren zu ihrer herstellung
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE69406077D1 (de) Verfahren zur Herstellung von 5-Amino-2,2-Dialkyl-1,3-Dioxan
ATE231858T1 (de) Verfahren zur herstellung von 3-substituierten 4- phenyl-piperidin derivaten
DE50105621D1 (de) 1h-pyrazol-derivate, verfahren zu ihrer herstellung und deren verwendung zur hemmung und steuerung der nitrifikation
ATE229500T1 (de) Verfahren zur herstellung von trion- bis(oximether) derivaten sowie damit erhältliche trion-mono- und trion-bis(oximether) derivate
ATE250042T1 (de) Verfahren zur herstellung von cyclen
ATE300534T1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
DE69619402D1 (de) Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten
ATE264829T1 (de) Verfahren zur herstellung von acylierten 1,3- dicarbonylverbindungen
ATE299147T1 (de) Verfahren zur herstellung von 3-amino-1,5- benzodiazepinderivaten
ATE366798T1 (de) Verfahren zur herstellung von pseudomycin aus pseudomonas syringae
ATE305928T1 (de) Verfahren zur herstellung von 4-brom-anilin- derivaten
ATE259774T1 (de) Verfahren zur herstellung von 6,6-dialkoxy-5- hydroxy-3-oxo-hexansäureestern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties